Skip to Main Content

Clinical Trials

Current Research and Projects


Centers for Disease Control and Prevention

Investigators: Dan Joseph, MD and Michael V. Pantalon, PhD

This project evaluates the efficacy of a recovery coach and paramedic team as an intervention following naloxone resuscitation from opioid overdose.

CONNECTS for Clinical Trials targeting macro-, micro-immuno-thrombosis, vascular hyperinflammation, and hypercoaguability and renin-angiotensin-aldosterone system (RAAS) in hospitalized patients with COVID-19 (ACTIV-4 Host Tissue)

National Institutes of Health/National Heart, Lung, and Blood Institute

Investigators: Basmah Safdar, MD

The overarching aim of NECTAR (Novel Experimental COVID-19 Therapies Affecting Host Response), a multisite trial is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients hospitalized for COVID-19 include hastening recovery and preventing progression of critical illness, multigrain failure, or death. The trial seeks to identify whether modulation of the host tissue response improves clinical outcomes among patients with COVID-19.

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase Study of the Efficacy and Safety of Patiromer for Oral Suspension in Combination with Standard of Care Treatment in Emergency Department Patients with Hyperkalemia (PLATINUM)

Comprehensive Research Associates LLC

Investigators: Basmah Safdar, MD

The aim of the trial is to investigate if Patiromer can help lower potassium levels in the acute settings.